Cocrystal Pharma Reports Third Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. IBM

Go back to Cocrystal Pharma Reports Third Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs

Cocrystal Pharma, Inc. (COCP) Misses Q3 EPS by 18c

November 14, 2022 8:11 AM EST

Cocrystal Pharma, Inc. (NASDAQ: COCP) reported Q3 EPS of ($0.70), $0.18 worse than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Cocrystal Pharma, Inc. (COCP) click here.

... More